Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...

Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® ...

As the COVID-19 pandemic continues into the fall, Roche Group is planning to launch its latest tool later this month. And while its SARS-CoV-2 Rapid Antigen Test will be available in markets accepting ...

U.S. consumers may already be familiar with Roche’s rapid antigen test for COVID-19. The mass-produced, at-home screener was distributed to tens of millions of people through the mail this year via ...

BERLIN, Oct 15 (Reuters) - Germany's health ministry has signed contracts with Abbot Laboratories (ABT.N), opens new tab, Roche (ROG.S), opens new tab and Siemens Healthineers (SHLG.DE), opens new tab ...

Roche can't rely indefinitely on COVID-19 tests to drive revenue growth. The company's pipeline is now focused towards laboratory-based diagnostics. Roche's target market has room for more and better ...

Omicron’s surge over January drove Roche’s diagnostics sales to new highs in the first quarter of this year, up 24% versus the same period in 2021. The sales bump came as the high demand for rapid ...

ZURICH/BERLIN, Oct 13 (Reuters) - Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued ...

Roche and Pfizer have launched a collaboration in the U.S. to help those who test positive for COVID-19 find the best resources for the best possible outcomes. Starting just in time for a potential ...